By Gusty Thursday, 30 July 2015 CHF clinical trials Entresto evidence-based medicine manipulating clinical research Novartis sacubitril Good Health and Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year. Elvonda The newest drug for congestive heart failure, Entresto, a fixed combination of valsartan and sacubitril, has just hit the market at an eleva...
By Gusty Wednesday, 1 July 2015 Clinton Foundation evidence-based medicine Gilead Hepatitis C Sovaldi Good Health and Bill Clinton, Paid to Speak to Biotech Conference, Extolled $1000 Pill to Prevent "Liver Rot," Despite Lack of Evidence that It Does. Elvonda What were they thinking? Former President Clinton Talkes to Pharma and Biotech Executives In mid June, 2015, the Philadelphia Inquirer repor...
By Gusty Monday, 18 May 2015 academic corruption conflict of interest evidence-based medicine institutional conflicts of interest NEJM pharmaceuticals physicians Good Health and . Elvonda Why is the New England Journal of Medicine Scolding "Pharmascolds"? I, a normally quiet blogger on this site, was disquieted by wh...
By Gusty Thursday, 26 February 2015 clinical trials conflicts of interest deception evidence-based medicine fda marketing Shire stealth marketing Good Health and Promoting Amphetamines for Over-Eating - What Could Possibly Go Wrong? . Elvonda Every day seems to bring the latest breathlessly touted innovation in modern health care. The endless hawking of new health care wonders is...